Brief: Iveric Bio Reports Third Quarter 2021 Financial Results
09/11/2021 11:38
Nov 9 (Reuters) - Iveric Bio Inc ISEE.O :
* IVERIC BIO REPORTS THIRD QUARTER 2021 OPERATIONAL
HIGHLIGHTS AND
FINANCIAL RESULTS
* Q3 LOSS PER SHARE $0.23
* IVERIC BIO - SEES CASH, CASH EQUIVALENTS & AVAILABLE FOR
SALE
SECURITIES SUFFICIENT TO FUND PLANNED CAPITAL EXPENDITURE &
EXPENSES AT LEAST MID-2024
Source text for Eikon: ID:nBw5Hj5Mga
Further company coverage: ISEE.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on IVERIC bio
See all newsBrief: Astellas Pharma Inc - Astellas Completes Acquisition Of Iveric Bio
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
Iveric Bio Inc Reports Results For The Quarter Ended In March: Earnings Summary
The end of cheap credit could hurry Japanese M&A
U.S. STOCKS ON THE MOVE-US banks, Biomea Fusion, Tutor Perini